• Explore /
  • Poster
  • / A phase I study of GC33 in Japanese patients with advanced hepatocellular carcinoma (HCC).

A phase I study of GC33 in Japanese patients with advanced hepatocellular carcinoma (HCC).

Abstract Poster

Authors

null

Takuji Okusaka

National Cancer Center Hospital

Takuji Okusaka , Masafumi Ikeda , Shinichi Ohkawa , Shunsuke Yamamoto , Ikue Suzuki , Junji Furuse

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

JapicCTI-101255

Citation

J Clin Oncol 31, 2013 (suppl 4; abstr235)

DOI

10.1200/jco.2013.31.4_suppl.235

Abstract #

235

Poster Bd #

B39

Abstract Disclosures

Similar Posters

First Author: Weijia Fang

First Author: Ghassan K. Abou-Alfa

First Author: R. S. Finn

Poster

2024 ASCO Gastrointestinal Cancers Symposium

Phase 1 trial of navitoclax and sorafenib in patients with refractory solid tumors with a hepatocellular carcinoma expansion cohort.

Phase 1 trial of navitoclax and sorafenib in patients with refractory solid tumors with a hepatocellular carcinoma expansion cohort.

First Author: Oluwadunni Eunice Emiloju